NP / PA
Bravo, Julio
Bravo, Julio was paid $625K by Medicaid between Aug 2022 and Dec 2024, across 24 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 23% of everything it billed.
33Billing provider infoBRAVO, JULIO
MISSION, TX 78573
MISSION, TX 78573
33aNPI1144568957assigned 01/29/2013
33bProvider typeFamily Nurse Practitioner
28Total paid$625K
24GClaims28,008
24DCodes billed24
24AFirst – last monthAug 2022 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Texas
Rank by total paid#22 of 344
Median peer was paid$14K
This provider vs. median45×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 9,309 | $204K | |
| 2023 | 12,838 | $294K | |
| 2024incomplete | 5,861 | $127K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 3,172 | 2,350 | $143K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 20% | 3,176 | 2,840 | $124K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 3,405 | 2,503 | $117K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 12% | 5,545 | 2,501 | $75K |
| S8301 | Infection control supplies, not otherwise specified | 11% | 2,898 | 1,958 | $71K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6.8% | 3,166 | 2,844 | $43K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.4% | 2,422 | 2,151 | $15K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.5% | 759 | 721 | $9K |
| 99000 | 1.2% | 797 | 757 | $8K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 53 | 53 | $5K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 350 | 148 | $5K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 48 | 47 | $4K |
12 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 25 | $2K |
| 92558 | <1% | 533 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 118 | $1K |
| 81003 | <1% | 506 | $902.39 | |
| 99050 | <1% | 21 | $288.82 | |
| 90461 | <1% | 59 | $242.30 | |
| 96161 | <1% | 94 | $131.31 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 13 | $106.08 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 759 | $33.78 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 41 | $6.17 |
| 36415 | Collection of venous blood by venipuncture | 0% | 32 | $0.00 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.